Home
Over UMC Utrecht
Contact & route
Vasculair Preventie Programma
Home
Achtergrond
Patiënten
Inhoud Preventie Programma
Slagaderverkalking
Risicofactoren
Van aanmelding tot uitslag
Voeding & Leefstijl
Kosten & Declaraties
Organisatiestructuur
Personeel
Vragen
Steun ons
Screening
Vasculaire screening
Tweede Vasculaire screening - SMART2
Verwijzers
Inhoud preventieprogramma
Welke patiënt?
Uitslagen
Definities en adviezen
Steun ons
Onderzoek
SMART Study Group
Eindpunten
Bedrijfsproces Substudies
Lopende studies
Voorgaande studies
Publicaties
Proefschriften
Vacatures
SMART in BBMRI
SMART Scientific English version
Links
Ziektebeelden
Risicofactoren
Patiëntenverenigingen
Leefstijl
Contact
Adres en route
Telefoonnummers
Onderzoek
SMART Study Group
Eindpunten
Bedrijfsproces Substudies
Lopende studies
Voorgaande studies
Publicaties
Bulletins
2011
2010
2009
2008
2007
2006
2005
2004
2003
2000-2002
1998-1999
Proefschriften
Vacatures
SMART in BBMRI
SMART Scientific English version
« Terug naar Onderzoek
2011
Print
Lees voor
Achterberg S, Visseren FLJ, Kappelle LJ et al.
Differential propensity of major haemorrhagic events in patients with different types of arterial diseases
. J Thromb Haemost 2011;1724-1729.
Achterberg S, Soedamah-Muthu SS, Cramer MJ, van der Graaf Y, Algra A, for the SMART Study Group.
Prognostic value of the Rose questionnaire: a validation with future coronary events in the SMART study
. Eur J Cardiovasc Prev Rehabil 2011;25 Feb Epub ahead of print.
Conijn MM, Kloppenborg RP, Algra A, Mali WP, Kappelle LJ, Vincken KL, van der Graaf Y, Geerlings MI; for the SMART Study Group.
Cerebral Small Vessel Disease and Risk of Death, Ischemic Stroke, and Cardiac Complications in Patients With Atherosclerotic Disease: The SecondManifestations of ARTerial disease-Magnetic Resonance (SMART-MR) Study
. Stroke. 2011 Nov;42(11):3105-3109.
Conijn MM, Hoogduin JM, van der Graaf Y, Hendrikse J, Luijten PR, Geerlings MI.
Microbleeds, lacunar infarcts, white matter lesions and cerebrovascular reactivity - A 7T study
. Neuroimage. 2011 Sep 10. [Epub ahead of print] PubMed PMID: 21930217.
Conijn MM, Geerlings MI, Biessels GJ, Takahara T, Witkamp TD, Zwanenburg JJ, Luijten PR, Hendrikse J.
Cerebral microbleeds on MR imaging: comparison between 1.5 and 7T
. AJNR Am J Neuroradiol. 2011 Jun-Jul;32(6):1043-9. Epub 2011 May 5. PubMed PMID: 21546463.
Gerritsen L, Comijs HC, van der Graaf Y, Knoops AJ, Penninx BW, Geerlings MI.
Depression, hypothalamic pituitary adrenal axis, and hippocampal and entorhinal cortex volumes--the SMART Medea study
. Biol Psychiatry. 2011 Aug 15;70(4):373-80. Epub 2011 Mar 24. PubMed PMID: 21439552.
Grool AM, van der Graaf Y, Mali WP, Witkamp TD, Vincken KL, Geerlings MI.
Location and progression of cerebral small-vessel disease and atrophy, and depressive symptom profiles: The Second Manifestations of ARTerial disease (SMART)-Medea study
. Psychol Med. 2011 Aug 11:1-12. [Epub ahead of print] PubMed PMID: 21835088.
Grool AM, van der Graaf Y, Mali WP, Witkamp TD, Vincken KL, Geerlings MI.
A reply to Sakthiswary & Das
(2011). Psychol Med. 2011 Nov 1:1-2. [Epub ahead of print] PubMed PMID: 22041295.
Grool AM, van der Graaf Y, Witkamp TD, Vincken KL, Mali WP, Geerlings MI.
Progression of White Matter Lesion Volume and Health-Related Quality of Life in Patients with Symptomatic Atherosclerotic Disease: The SMART-MR Study
. J Aging Res. 2011;2011:280630. Epub 2011 Oct 16. PubMed PMID: 22013526; PubMed Central PMCID: PMC3195506.
Grool AM, van der Graaf Y, Mali WP, Geerlings MI; SMART Study Group.
Location of cerebrovascular and degenerative changes, depressive symptoms and cognitive functioning in later life: the SMART-Medea study
. J Neurol Neurosurg Psychiatry. 2011 Oct;82(10):1093-100. Epub 2011 Apr 1. PubMed PMID: 21459931.
Grool AM, van der Graaf Y, Visseren FLJ et al.
Self-rated health status as a risk factor for future cardiovascular events and mortality in patients with symptomatic and asymptomatic atherosclerotic disease.
The SMART study. J Intern Med 2011.
Jochemsen HM, Muller M, van der Graaf Y, Geerlings MI.
APOE ε4 differentially influences change in memory performance depending on age. The SMART-MR study. Neurobiol Aging.
2011 Sep 9. [Epub ahead of print] PubMed PMID: 21908077.
Kloppenborg RP, Nederkoorn PJ, van der Graaf Y, Geerlings MI.
Homocysteine and cerebral small vessel disease in patients with symptomatic atherosclerotic disease. The SMART-MR study.
Atherosclerosis. 2011 Jun;216(2):461-6. Epub 2011 Feb 24. PubMed PMID: 21411090.
Kuijf HJ, de Bresser J, Geerlings MI, Conijn MM, Viergever MA, Biessels GJ, Vincken KL.
Efficient detection of cerebral microbleeds on 7.0T MR images using the radial symmetry transform
. Neuroimage. 2011 Oct 2. [Epub ahead of print] PubMed PMID: 21985903.
Muller M, van der Graaf Y, Algra A, Hendrikse J, Mali WP, Geerlings MI; SMART Study Group.
Carotid atherosclerosis and progression of brain atrophy: the SMART-MR study
. Ann Neurol. 2011 Aug;70(2):237-44. doi: 10.1002/ana.22392. Epub 2011 Jun 14. PubMed PMID: 21674583.
Pruissen DMO, Rosendaal FR, Frijns CJM et al.
Prothrombotic gene variants and mortality after cerebral ischemia of arterial origin
. Neuroepidemiol 2011;37:109-113.